Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
NorthWestern Energy
NWE
$4.35B
| $7.92M | ﹤0.01% |
154,416
+28,575
| +23% | +$1.58M |
|
1727
Matsons
MATX
$6.11B
| $7.92M | ﹤0.01% |
71,084
-2,514
| -3% | -$275K |
|
1728
Oscar Health
OSCR
$8.63B
| $7.91M | ﹤0.01% |
369,158
+96,165
| +35% | +$1.43M |
|
1729
Synaptics
SYNA
$4.18B
| $7.91M | ﹤0.01% |
122,074
+36,776
| +43% | +$2.16M |
|
1730
Starwood Property Trust
STWD
$6.17B
| $7.9M | ﹤0.01% |
393,471
-14,415
| -4% | -$280K |
|
1731
Mirum Pharmaceuticals
MIRM
$5.99B
| $7.88M | ﹤0.01% |
154,871
+73,567
| +90% | +$3.28M |
|
1732
iShares Russell 2000 Value ETF
IWN
$14.6B
| $7.88M | ﹤0.01% |
49,942
-57,883
| -54% | -$8.62M |
|
1733
Resideo Technologies
REZI
$3.67B
| $7.88M | ﹤0.01% |
357,058
+165,305
| +86% | +$3.15M |
|
1734
CALL
Labcorp
LH
$26.1B
| $7.88M | ﹤0.01% |
+30,000
| New | +$7.31M |
|
1735
Universal Technical Institute
UTI
$1.4B
| $7.87M | ﹤0.01% |
232,334
+35,452
| +18% | +$1.11M |
|
1736
CALL
monday.com
MNDY
$3.7B
| $7.86M | ﹤0.01% |
25,000
| – | – |
|
1737
Jones Lang LaSalle
JLL
$16.7B
| $7.84M | ﹤0.01% |
30,632
-7,978
| -21% | -$1.83M |
|
1738
Renasant Corp
RNST
$3.92B
| $7.83M | ﹤0.01% |
218,029
+118,999
| +120% | +$3.97M |
|
1739
Genius Sports
GENI
$2.16B
| $7.83M | ﹤0.01% |
752,941
+249,641
| +50% | +$2.5M |
|
1740
PUT
Boyd Gaming
BYD
$5.98B
| $7.82M | ﹤0.01% |
+100,000
| New | +$7.14M |
|
1741
Travere Therapeutics
TVTX
$5.68B
| $7.82M | ﹤0.01% |
528,526
-293,306
| -36% | -$4.86M |
|
1742
Marqeta
MQ
$1.62B
| $7.82M | ﹤0.01% |
335,247
+54,518
| +19% | +$1.03M |
|
|
ALE
1743
DELISTED
Allete
ALE
| $7.82M | ﹤0.01% |
121,987
+28,789
| +31% | +$1.87M |
|
1744
Semtech
SMTC
$12.2B
| $7.8M | ﹤0.01% |
172,772
-105,593
| -38% | -$3.76M |
|
1745
Alarm.com
ALRM
$2.77B
| $7.78M | ﹤0.01% |
137,535
+46,407
| +51% | +$2.57M |
|
1746
FNB Corp
FNB
$6.8B
| $7.77M | ﹤0.01% |
532,993
-235,036
| -31% | -$3.18M |
|
1747
Timken Company
TKR
$8.91B
| $7.76M | ﹤0.01% |
106,892
+58,533
| +121% | +$3.98M |
|
1748
Amer Sports
AS
$19.7B
| $7.75M | ﹤0.01% |
199,885
+181,447
| +984% | +$5.58M |
|
1749
Twist Bioscience
TWST
$7.72B
| $7.75M | ﹤0.01% |
210,563
+96,150
| +84% | +$3.32M |
|
1750
Advance Auto Parts
AAP
$3.19B
| $7.74M | ﹤0.01% |
166,546
+82,811
| +99% | +$3.32M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.